EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Effectiveness of Nirsevimab on Antibiotic Use in Children Using Target Trial Emulation

Mahaa M Ahmed, Torsten Joerger iD, Ziyi Wang, Yun Li iD, Jeffrey S Gerber iD

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciag406 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Mahaa M Ahmed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Futures, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Respiratory Syncytial Virus Infections, Respiratory Tract Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Infectious, Infectious Diseases Society of America, Emerging Researchers/Clinicians Mentorship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nirsevimab is a monoclonal antibody with demonstrated efficacy in preventing respiratory syncytial virus (RSV) infections in infants. Because acute respiratory tract infections (ARTIs), including viral infections, often lead to antibiotic prescribing, we aimed to determine the effectiveness of nirsevimab on antibiotic prescribing among infants with medically attended ARTIs.

Methods

A primary care attendee cohort was established using electronic health record data from 32 diverse practices across a healthcare network to emulate a target trial comparing nirsevimab to no treatment among infants <8 months. Eligible infants were seen at a primary care practice within 14 days of life. Primary outcomes included time to first antibiotic prescription for (1) outpatient ARTIs, (2) outpatient encounters for bronchiolitis, and (3) RSV-related hospitalizations. Nirsevimab effectiveness was calculated as 1 minus the risk ratio for each primary outcome.

Results

Among 15 341 patients who met inclusion criteria, 7413 received nirsevimab. Compared with no treatment, nirsevimab administration led to a 14.4% (95% CI: 7.8%, 20.6%) reduction in antibiotic prescribing for outpatient ARTIs, a 40.3% (95% CI: 25.1%, 52.5%) reduction in antibiotic prescribing for outpatient bronchiolitis, and a 69.4% (95% CI: 4.8%, 90.1%) reduction in antibiotic prescribing for RSV-related hospitalizations.

Conclusions

Nirsevimab administration in primary care reduced antibiotic use for ARTIs in both ambulatory and inpatient settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsHumansInfantMaleFemaleHospitalizationBronchiolitisPrimary Health CareInfant, NewbornTreatment Outcome

Stichwörter der Autor:innen

RSVantibioticscausal inferencenirsevimabvaccine

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Clinical Futures, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Department of Pediatrics, Division of Infectious Diseases, University of Pennsylvania Perelman School of Medicine and Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Torsten Joerger, Yun Li, Jeffrey S Gerber

Förderung

  • Infectious
  • Infectious Diseases Society of America
  • Emerging Researchers/Clinicians Mentorship
  • MMA
  • Diseases Society of America's
  • Diseases Society of America’s

Zitieren

APA

Ahmed, M. M., Joerger, T., Wang, Z., Li, Y., & Gerber, J. S. (2026). The Effectiveness of Nirsevimab on Antibiotic Use in Children Using Target Trial Emulation. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag406

Vancouver

Ahmed MM, Joerger T, Wang Z, Li Y, Gerber JS. The Effectiveness of Nirsevimab on Antibiotic Use in Children Using Target Trial Emulation. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag406

BibTeX
@article{Ahmed2026,
  author = {Ahmed, Mahaa M and Joerger, Torsten and Wang, Ziyi and Li, Yun and Gerber, Jeffrey S},
  title = {The Effectiveness of Nirsevimab on Antibiotic Use in Children Using Target Trial Emulation},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag406}
}
Kostenlos starten →